H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.9% of adults in Murfreesboro have diagnosed diabetes — 2.1 points below the U.S. 12% figure. Census population 152,769. Tennessee Medicare wound biologics: Palmetto GBA (JJ). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Murfreesboro clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Murfreesboro storefront.
Growth Factor Therapy for Tissue Repair in Murfreesboro, TN for clinics & physicians. Growth factor therap… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of growth factor therapy in Murfreesboro: (1) CDC PLACES (2023, crude) estimates 9.9% of adults in Murfreesboro have diagnosed diabetes — 2.1 points below the U.S. 12% figure. (2) Tennessee Part B wound biologics are reviewed by Palmetto GBA under JJ, shared with AL, GA. We help with the second file. We do not pretend to be a Murfreesboro storefront.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)Tennessee shares JJ with AL, GA. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 9.9% of adults in Murfreesboro have diagnosed diabetes — 2.1 points below the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 9.9% of adults in Murfreesboro have diagnosed diabetes — 2.1 points below the U.S. 12% figure. Adult arthritis here is 24.4% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Murfreesboro.
CDC PLACES (2023, crude prevalence) estimates 9.9% of adults — 2.1 points below the U.S. 12% figure. Obesity is 37.3%; arthritis is 24.4%. That is place-level BRFSS modeling, not a clinic census and not a Murfreesboro trial.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow Palmetto GBA CTP articles. Mixing those codes is a billing error.
No. areaServed names the city we will ship to. It is not a claim that Hawk Medical is a Murfreesboro medical practice or that we hold a local facility license.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
Bring specialty, monthly joint / regenerative volume, and whether you bill JJ FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 9.9% diabetes and 24.4% arthritis for Murfreesboro — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Murfreesboro, TN.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Murfreesboro is JJ geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Murfreesboro — 2.1 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Tennessee Part B wound biologics follow this contractor (siblings: AL, GA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Murfreesboro. Useful for joint-program math; still needs a diagnosis and privileging.
No Murfreesboro storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.